Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05143684
Other study ID # LUD-CS
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2020
Est. completion date July 31, 2020

Study information

Verified date November 2021
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: Left uterine displacement (LUD) has been questioned as an effective strategy to prevent aortocaval compression after spinal anesthesia (SA) for cesarean delivery (CD). The investigators tested if LUD has a significant impact on cardiac output (CO) in patients undergoing CD under SA during continuous non-invasive hemodynamic monitoring. Methods: Forty-six patients were included in the final analysis. The investigators considered 4 timepoints of 5 minutes each: T1=baseline with LUD; T2=baseline without LUD; T3=after SA with LUD; T4=after SA without LUD. LUD was then repositioned for CD. Primary outcome was to test if CO decreased from T3 to T4. We also compared CO between T1 and T2 and other hemodynamic variables: mean, systolic and diastolic blood pressure (respectively MAP, SAP and DAP), heart rate (HR), stroke volume (SV), stroke volume variation (SVV), pulse pressure variation (PPV), contractility (dP/dt), dynamic arterial elastance (Eadyn) at the different timepoints. Data on fetal Apgar scores and umbilical arterial and venous pH were collecte


Description:

The primary outcome was to test if CO decreases significantly after LUD removal in patients under SA for CD. This is a prospective observational study. Data were gathered from pregnant patients who, in addition to standard monitoring, underwent perioperative non-invasive hemodynamic monitoring by ClearSight system on the Edwards Lifesciences HemoSphere platform (Edwards Lifesciences, Irvine, CA). The parameters were recorded at 20 seconds-intervals. The investigators considered 4 timepoints. T1 were the baseline values recorded for 5 minutes, after initial stabilization of parameters, with the patient laying down on the operating table with LUD. At T2, LUD was removed and we considered for the analysis hemodynamic data of the subsequent 5 minutes. The investigators indicated as T3 the 5 minutes following SA with a satisfactory sensory block and as T4 the subsequent 5 minutes following LUD removal. Figure 1 summarizes the timepoints of our analysis. LUD was accomplished by positioning a wooden wedge wrapped with cotton, to make it comfortable, and medical sheets with a measured angle of 15° under the right flank of the laying down patient. In all patients, after T4 the 15° wooden wedge was positioned again and surgery was performed with LUD. Anesthesia was standard spinal procedure, fluid management was left to the attending anesthesiologist. The attending anesthesiologist was blinded to the advanced hemodynamic parameters from the ClearSight system except for the continuous BP values. The investigators defined hypotension as an absolute value of MAP < 65 mmHg. This value was considered as trigger for the attending anesthesiologist for the administration of norepinephrine 5 mcg. Norepinephrine boluses were repeated to reach a MAP>65mmHg. Bradycardia was defined as a heart rate of < 60 bpm. Atropine 0.5 mg was administered for the treatment of bradycardia combined with hypotension, or for an absolute value of heart rate < 45 bpm. After delivery, Oxytocin was administered to facilitate the uterine contraction. We also evaluated the impact of maternal blood pressure and CO on fetal outcome collecting neonatal Apgar scores at 1 and 5 minutes after birth, and umbilical cord arterial and venous pH.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date July 31, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - pregnant patients at term (36th to 40th week of gestation) scheduled for elective caesarean section under spinal anesthesia. Exclusion Criteria: - age <18 years - American Society of Anesthesiologists score >3 - cardiac arrhythmias or aortic regurgitation - pregnancy-induced hypertension - pre-eclampsia - body mass index (BMI) > 35 kg/m2 - foetal complications - coagulation disorders or contraindication to neuraxial block - emergency surgery - preoperative infection - patient's refusal

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Left Lateral Uterine Displacement
a wooden wedge wrapped with cotton, to make it comfortable, and medical sheets with a measured angle of 15° under the right flank of the laying down patient

Locations

Country Name City State
Italy IRCCS Fondazione Policlinico Universitario Agostino Gemelli Rome

Sponsors (1)

Lead Sponsor Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiac Output (l/min) measured by non-invasive hemodynamic monitoring Does cardiac output decrease significantly after left lateral uterine displacement removal in patients under spinal anesthesia for caesarean delivery? at 5 minutes from left lateral uterine tilt removal under spinal anesthesia
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05970770 - Hypotension Prediction Index vs Norepinephrine Infusion for Prevention of Spinal Hypotension for Cesarean Delivery Phase 4
Recruiting NCT03626454 - Norepinephrine Addition in Spinal Anesthesia of Caesarean Section N/A
Completed NCT03834454 - Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population N/A
Recruiting NCT05661942 - Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate Phase 4
Recruiting NCT05079269 - Pre-op Fluid Study N/A
Completed NCT02967029 - Effect of Controlled Hypotension on Cerebral Oxygen Saturation Phase 4
Recruiting NCT06334549 - A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia Phase 4
Not yet recruiting NCT03465943 - Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia Early Phase 1
Not yet recruiting NCT03478618 - Comparison of Different Protocols of Fluid Therapy in Severe Preeclamptic Patients Under Spinal Anesthesia Early Phase 1
Recruiting NCT06259760 - AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia
Recruiting NCT03743870 - Spinal Anesthesia in Caesarean Section
Completed NCT02979405 - Effectiveness of Phenylefrine in Prevention of Hypotension During Spinal Anesthesia for Cesarean Delivery Phase 4
Completed NCT05101291 - Fractional Spinal Anesthesia and Systemic Hemodynamics in Frail Elderly Hip Fracture Patients. N/A
Recruiting NCT04914234 - Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries Phase 4
Completed NCT05502146 - Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension Phase 4
Completed NCT05368376 - Is Labetalol More Effective Than Metoprolol for Controlled Hypotensive Anesthesia During Endoscopic Nasal Surgeries? Phase 4
Completed NCT04865614 - Comparison Between Inhalation and Intravenous Induction of Anaesthesia During Interventional Mitral Valve Repair